![Kaye Reiter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Kaye Reiter
Sociétés | Poste | Début | Fin |
---|---|---|---|
Pluristyx, Inc.
![]() Pluristyx, Inc. BiotechnologyHealth Technology Pluristyx, Inc. is a privately held biotechnology company that helps industry and academic researchers solve manufacturing and analytical challenges in cryopreservation, drug development, regenerative medicine, and cell and gene therapy. The company is based in Seattle, WA and has subsidiaries in United States and Canada. The company has decades of experience supporting every stage of cell therapy product development, from cell banking to drug product manufacturing including analytical testing and release of clinical grade cell therapy products. Pluristyx offers consulting, wet-lab services, and pluripotent stem cell products to support novel therapeutic developers. The company was founded in 2018 by Kaye Reiter, Benjamin Fryer, Jason Carstens. Benjamin Fryer has been the CEO since 2018. | Fondateur | 01/01/2018 | - |
Conseiller Juridique Général | 01/01/2018 | - |
Historique de carrière de Kaye Reiter
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Founder | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Pluristyx, Inc.
![]() Pluristyx, Inc. BiotechnologyHealth Technology Pluristyx, Inc. is a privately held biotechnology company that helps industry and academic researchers solve manufacturing and analytical challenges in cryopreservation, drug development, regenerative medicine, and cell and gene therapy. The company is based in Seattle, WA and has subsidiaries in United States and Canada. The company has decades of experience supporting every stage of cell therapy product development, from cell banking to drug product manufacturing including analytical testing and release of clinical grade cell therapy products. Pluristyx offers consulting, wet-lab services, and pluripotent stem cell products to support novel therapeutic developers. The company was founded in 2018 by Kaye Reiter, Benjamin Fryer, Jason Carstens. Benjamin Fryer has been the CEO since 2018. | Health Technology |
- Bourse
- Insiders
- Kaye Reiter
- Expérience